Brachio-cervical inflammatory myopathies: Clinical, immune, and myopathologic features

Arthritis and Rheumatism

Volumn 54, Issue 5, 2006, Pages 1687-1696

  Pestronk, Alan ^a   Kos, Ksenija ^b   Lopate, Glenn ^a   Al Lozi, Muhammad T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST JOHN S MERCY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT MEMBRANE ATTACK COMPLEX; CORTICOSTEROID; CREATINE KINASE;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BRACHIOCERVICAL INFLAMMATORY MYOPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN TISSUE; MALE; MONONUCLEAR CELL; MUSCLE BIOPSY; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; MYOSITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED, 80 AND OVER; ARM; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOSITIS; NECK MUSCLES; RETROSPECTIVE STUDIES; SYNDROME;

EID: 33646483653     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21822     Document Type: Article

References (36)

1. Dorph C, Lundberg IE. Idiopathic inflammatory myopathies: myositis. Best Pract Res Clin Rheumatol 2002;16:817-32.
2. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971-82.
3. Mastaglia FL, Garlepp MJ, Phillips BA, Zilko PJ. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects. Muscle Nerve 2003;27:407-25.
4. Nirmalananthan N, Holton JL, Hanna MG. Is it really myositis? A consideration of the differential diagnosis. Curr Opin Rheumatol 2004;16:684-91.
5. Miller T, Al Lozi MT, Lopate G, Pestronk A. Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Psychiatry 2002;73:420-8.
6. Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum 2004;50:209-15.
7. Wedderburn LR, Li CK. Paediatric idiopathic inflammatory muscle disease. Best Pract Res Clin Rheumatol 2004;18:345-58.
8. Schmidt WA, Wetzel W, Friedlander R, Lange R, Sorensen HF, Lichey HJ, et al. Clinical and serological aspects of patients with anti-Jo-1 autoantibodies: an evolving spectrum of disease manifestations. Clin Rheumatol 2000;19:371-7.
9. Fathi M, Dastmalchi M, Rasmussen E, Lundberg IE, Tornling G. Interstitial lung disease: a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 2004;63:297-301.
10. Kissel JT, Halterman RK, Rammohan KW, Mendell JR. The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis. Arch Neurol 1991;48:26-30.
11. Mozaffar T, Pestronk A. Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres. J Neurol Neurosurg Psychiatry 2000;68:472-8.
12. Rostasy KM, Piepkorn M, Goebel HH, Menck S, Hanefeld F, Schulz-Schaeffer WJ. Monocyte/macrophage differentiation in dermatomyositis and polymyositis. Muscle Nerve 2004;30:225-30.
13. Dalakas MC. Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin North Am 2002;28:779-98.
14. Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-13.
15. Pestronk A, Lopate G, Kornberg AJ, Elliott JL, Blume G, Yee WC, et al. Distal lower motor neuron syndrome with high-liter serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cydophosphamide. Neurology 1994;44:2027-31.
16. Medical Research Council. Aids to the investigation of peripheral nerve injury. War Memorandum 45. London: Her Majesty's Stationary Office; 1943.
17. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. IV: Cell-mediated cytotoxicity and muscle fiber necrosis. Ann Neurol 1988;23:168-73.
18. Emslie-Smith AM, Engel AG. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 1990;27:343-56.
19. Levin MI, Mozaffar T, Al-Lozi MT, Pestronk A. Paraneoplastic necrotizing myopathy: clinical and pathological features. Neurology 1998;50:764-7.
20. Pestronk A, Chaudhry V, Feldman EL, Griffin JW, Cornblath DR, Denys EH, et al. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities and high titers of antiglycolipid antibodies. Ann Neurol 1990;27:316-26.
21. Katz JS, Wolfe GI, Andersson PB, Saperstein DS, Elliott JL, Nations SP, et al. Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder. Neurology 1999;53:1071-6.
22. Van den Berg-Vos RM, Visser J, Franssen H, de Visser M, de Jong JM, Kalmijn S, et al. Sporadic lower motor neuron disease with adult onset: classification of subtypes. Brain 2003;126:1036-47.
23. Vattemi G, Tonin P, Filosto M, Savio C, Rizzuto N, Tomelleri G. Reversible upper limb muscle weakness with selective loss of thick filaments. Neurology 2003;61:863-4.
24. Wolfe GI, Baker NS, Haller RG, Burns DK, Barohn RJ. McArdle's disease presenting with symmetric, late-onset arm weakness. Muscle Nerve 2000;23:641-5.
25. Gourie-Devi M, Nalini A, Sandhya S. Early or late appearance of "dropped head syndrome" in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2003;74:683-6.
26. Puruckherr M, Pooyan P, Dube D, Byrd RP, Roy TM. The dropped head sign: an unusual presenting feature of myasthenia gravis. Neuromuscul Disord 2004;14:378-9.
27. De Bleecker DL, Engel AG, Butcher AC. Peripheral lymphoid tissue-like adhesion molecule expression in nodular infiltrates in inflammatory myopathies. Neuromuscul Disord 1996;6:255-60.
28. Umapathi T, Chaudhry V, Cornblath D, Drachman D, Griffin J, Kuncl R. Head drop and camptocormia. J Neurol Neurosurg Psychiatry 2002;73:1-7.
29. Van de Warrenburg BP, Hengstman GJ, Vos PE, Boerman RH, ter Laak HJ, Van Engelen BG. Concomitant dermatomyositis and myasthenia gravis presenting with respiratory insufficiency. Muscle Nerve 2002;25:293-6.
30. Pestronk A, Drachman DB, Self SG. Measurement of junctional acetylcholine receptors in myasthenia gravis: clinical correlates. Muscle Nerve 1985;8:245-51.
31. Pestronk A, Drachman DB. Polymyositis: reduction of acetylcholine receptors in skeletal muscle. Muscle Nerve 1985;8:233-9.
32. Mygland A, Vincent A, Newsom-Davis J, Kaminski H, Zorzato F, Agius M, et al. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia. Arch Neurol 2000;57:527-31.
33. Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R, et al. Interferon-α/β-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 2005;57:664-78.
34. Engel A, Biesecker G. Complement activation in muscle fiber necrosis: demonstration of the membrane attack complex of complement in necrotic fibers. Ann Neurol 1982;12:289-96.
35. Al-Lozi MT, Pestronk A, Choksi R. A skeletal muscle-specific form of decorin is a target antigen for a serum IgM M-protein in a patient with a proximal myopathy. Neurology 1997;49:1650-4.
36. Van der Meulen MF, Bronner IM, Hoogendijk JE, Burger H, van Venrooij WJ, Voskuyl AE, et al. Polymyositis: an overdiagnosed entity. Neurology 2003;61:316-21.